In randomized study, ensartinib doubled PFS versus first-generation ALK inhibitor
Spending reached $4.9 trillion, with spending on physician and clinical services up 7.4%
South Carolina governor says that any public money "results in the subsidy of abortion"
Where medicine is all fun and games
You passed medical training, now see if you can pass our weekly quiz
Multi-step, condition-based, and doctor-reviewed resource library for physicians and their patients.See All Medical Journeys >
Biomarker of wine consumption believed to reduce misclassification and bias in study
Researchers also examined MRD to guide treatment decisions, and other personalized approaches
Surgeons' groups acknowledge that prophylactic antibiotics may not cut infection risk
In some cases, public anger has yielded more headaches for patients
Approaches include evidence-based treatments, drug courts, harm reduction
Campaigns motivated by working conditions, lack of voice in management, and patient care concerns
This past week in healthcare investigations
Health news and commentary gathered by 乌鸦传媒 staff
Agreement would reduce a 2.8% cut to 0.3%, but doesn't include prior authorization reform
"We're really not there"
Clinical trials of xenotransplantation expected to kick off next year
The spinal condition is more common among people in their 50s and older
News and commentary from the world of neurology and neuroscience
Recent developments of interest in cardiovascular medicine
Also in TTHealthWatch: depression treatment after positive screening in primary care
乌鸦传媒 reporters offer further insights into recently covered topics
Three physicians face crossroads in patient care
A discussion with the former CEO of the Bill & Melinda Gates Foundation
Science and public health turned survival into the norm, says Perri Klass, MD
An examination of what's driving sexual violence against women in medicine
This newly approved testing modality brings challenges and opportunities
Unequal access threatens to worsen disparities
The potential benefits of CAR T-cell therapies still far outweigh the risks